240
Views
0
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Modulating Anxiety and Functional Capacity with Anodal tDCS Over the Left Dorsolateral Prefrontal Cortex in Primary Dysmenorrhea

ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 243-251 | Published online: 05 Apr 2020

Figures & data

Figure 1 CONSORT flowchart for the study.

Figure 1 CONSORT flowchart for the study.

Figure 2 Research protocol.

Notes: ƚOutcome evaluated on first, second, and third days of menstruation. *All outcomes evaluated only on the first day of menstruation.

Figure 2 Research protocol.Notes: ƚOutcome evaluated on first, second, and third days of menstruation. *All outcomes evaluated only on the first day of menstruation.

Table 1 Sociodemographic and Clinical Variables

Figure 3 (A, B) Mean changes in numeric rating scale (NRS) assessed for 3 consecutive days before treatment (baseline) and after intervention. *Significant difference in active tDCS when comparing day 1 to day 3. Percentages describes the difference between day 1 and day 3 in each group. (C, D) No significant changes in positive and negative affect were found. (E) Anxiety showed a significant difference between day 1 and day 3 in active tDCS. (F) Six-Minute Walk Test (6MWT) indicates statistically significant differences between groups of intervention** and in intragroup analysis for active tDCS*.

Figure 3 (A, B) Mean changes in numeric rating scale (NRS) assessed for 3 consecutive days before treatment (baseline) and after intervention. *Significant difference in active tDCS when comparing day 1 to day 3. Percentages describes the difference between day 1 and day 3 in each group. (C, D) No significant changes in positive and negative affect were found. (E) Anxiety showed a significant difference between day 1 and day 3 in active tDCS. (F) Six-Minute Walk Test (6MWT) indicates statistically significant differences between groups of intervention** and in intragroup analysis for active tDCS*.